Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Public Participation in the Patent System Will Lower Drug Costs
Report Finds 89% of Total U.S. Patent Applications on Humira Were Filed After FDA Approval – Pointing to a Deliberate Strategy to Delay Competition
How High-Priced Drugs Cripple Prison Health Care—and Reform
Femtastic Podcast: How Patent Law Affects Your Health
I-MAK Welcomes Two New Board Members to Champion the Access to Medicines Movement
Patent abuse is driving up drug prices. Just look at Lantus
Wall Street Wants the Best Patents, Not the Best Drugs
Pharma patent owners in the US are under pressure like they have never been before
Women Are Being Hurt the Most by the Drug Pricing Crisis
A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused